Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Pfizer describes potent new phosphodiesterase inhibitors and potential therapeutic uses

May 29, 2001

Merck presents amine derivatives with PDE5-inhibitory effects

May 21, 2001

Preparation and therapeutic uses of new alpha1A-adrenoceptor antagonists disclosed by Synaptic

May 18, 2001

EMD-221963, a representative NHE-3 inhibitor from Merck KGaA

May 17, 2001

NDA filed in Hong Kong for NexMed's ED treatment

May 16, 2001

Tanabe Seiyaku issued patent covering new PDE5 inhibitors and their use

May 11, 2001

Watson seeks FDA approval for overactive bladder treatment

May 4, 2001

Kissei and Daiichi will codevelop and comarket BPH Rx in Japan

May 3, 2001

Cialis demonstrates extended duration in clinical trials in ED

May 3, 2001

Tolterodine ER shows improved efficacy and safety

May 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...